Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine


  1. Published

    When should antiretroviral therapy for HIV be started?

    Phillips, A. N., Gazzard, B. G., Clumeck, N., Losso, M. H. & Lundgren, Jens, 2007, In: B M J. 334, 7584, p. 76-78 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    When is the best time to initiate antiretroviral therapy?

    Borges, Á. H. & Lundgren, Jens, Aug 2015, In: The Lancet HIV. 2, 8, p. e312-3

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

    Viard, J., Souberbielle, J., Kirk, Ole, Reekie, J., Knysz, B., Losso, M., Gatell, J., Pedersen, C., Bogner, J. R., Lundgren, Jens, Mocroft, A. & Eurosida Study Group, E. S. G., 2011, In: AIDS. 25, 10, p. 1305-1315

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Virological rebound after suppression o­n highly active antiretroviral therapy.

    Mocroft, A., Ruiz, L., Reiss, P., Ledergerber, B., Katlama, C., Lazzarin, A., Goebel, F., Phillips, A., Clotet, B. & Lundgren, Jens, 2003, In: AIDS.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Virological failure among patients o­n HAART from across Europe: results from the EuroSIDA study

    Mocroft, A., Miller, V., Chiesi, A., Blaxhult, A., Katlama, C., Clotet, B., Barton, S. & Lundgren, Jens, 2000, In: Antiviral Therapy.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited.

    Moore, A., Kirk, O., Johnson, A., Katlama, C., Blaxhult, A., Dietrich, M., Colebunders, R., Chiesi, A., Lundgren, Jens & Phillips, A., 2003, In: J A I D S.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium

    Neesgaard, B., Mocroft, A., Zangerle, R., Wit, F., Lampe, F., Günthard, H. F., Necsoi, C., Law, M., Mussini, C., Castagna, A., Monforte, A. DA., Pradier, C., Chkhartisvilli, N., Reyes-Uruena, J., Vehreschild, J. J., Wasmuth, J-C., Sönnerborg, A., Stephan, C., Greenberg, L., Llibre, J. M. & 16 others, Volny-Anne, A., Peters, L., Pelchen-Matthews, A., Vannappagari, V., Gallant, J., Rieger, A., Youle, M., Braun, D., De Wit, S., Petoumenos, K., Borghi, V., Spagnuolo, V., Tsertsvadze, T., Lundgren, Jens, Ryom, L. & RESPOND Study Group, R. S. G., 2020, In: PLoS ONE. 15, 12, 19 p., e0243625.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen

    Fox, Z., Phillips, A., Cohen, C., Neuhaus, J., Baxter, J., Emery, S., Hirschel, B., Hullsiek, K. H., Stephan, C., Lundgren, Jens & SMART Study Group, S. S. G., 2008, In: AIDS. 22, 17, p. 2279-89 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients.

    Phillips, A., Pradier, C., Lazzarin, A., Clotet, B., Goebel, F., Hermans, P., Antunes, F., Ledergerber, B., Kirk, O. & Lundgren, Jens, 2001, In: AIDS.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations

    Domingo, P. & Eurosida Study Group, E. S. G., 2018, In: AIDS. 32, 18, p. 2807-2819 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...69 Next

ID: 13961